ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CADL Candel Therapeutics Inc

7.76
0.71 (10.07%)
May 01 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,099,623
Bid Price 7.70
Ask Price 7.75
News -
Day High 7.98

Low
0.66

52 Week Range

High
11.3999

Day Low 6.94
Share Name Share Symbol Market Stock Type
Candel Therapeutics Inc CADL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.71 10.07% 7.76 18:59:47
Open Price Low Price High Price Close Price Previous Close
7.03 6.94 7.98 7.98 7.05
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
5,841 1,099,623 US$ 7.35 US$ 8,080,841 - 0.66 - 11.3999
Last Trade Type Quantity Price Currency
18:56:41 50 US$ 7.76 USD

Candel Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
230.49M 28.92M - 0 -37.94M -1.31 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Candel Therapeutics News

Date Time Source News Article
4/25/202407:00GlobeNewswire Inc.Candel Therapeutics Announces Upcoming Presentations at the..
4/11/202408:00GlobeNewswire Inc.Candel Therapeutics Receives FDA Orphan Drug Designation for..
4/09/202407:00GlobeNewswire Inc.Candel Therapeutics Presents Preclinical Data at AACR on..
4/04/202407:00GlobeNewswire Inc.Candel Therapeutics Announces Positive Interim Data from..
3/28/202415:05GlobeNewswire Inc.Candel Therapeutics Announces Oral Presentation During the..
3/28/202407:05GlobeNewswire Inc.Candel Therapeutics Reports Fourth Quarter and Full Year..
3/06/202407:00Edgar (US Regulatory)Form 8-K - Current report
3/05/202415:30GlobeNewswire Inc.Candel Therapeutics Announces an Upcoming Presentation at..
2/13/202408:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
2/13/202406:45Edgar (US Regulatory)Form 8-K - Current report
2/13/202406:30GlobeNewswire Inc.CAN-3110 Receives FDA Fast Track Designation for Treatment..
2/05/202407:00GlobeNewswire Inc.Candel Therapeutics Sets Path to Success: Recent..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CADL Message Board. Create One! See More Posts on CADL Message Board See More Message Board Posts

Historical CADL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week6.047.985.716.56655,5221.7228.48%
1 Month1.7011.39991.566.6016,294,4056.06356.47%
3 Months1.2911.39991.216.545,694,5956.47501.55%
6 Months0.9011.39990.666.012,947,0396.86762.22%
1 Year1.2911.39990.665.971,472,5026.47501.55%
3 Years8.0014.780.665.98563,472-0.24-3.00%
5 Years8.0014.780.665.98563,472-0.24-3.00%

Candel Therapeutics Description

Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.

Your Recent History

Delayed Upgrade Clock